Status:
UNKNOWN
Analysis of Prognostic and Predictive Genomic Signatures Using Archival Paraffin-embedded Tumor Specimens in Breast Cancer
Lead Sponsor:
National University Hospital, Singapore
Conditions:
Breast Tumor
Eligibility:
FEMALE
Brief Summary
Major Aims of study: 1. To create a gene expression-based prognostic device that complements or exceeds the prognostic utility of conventional biomarkers of breast cancer outcome. 2. To identify one ...
Detailed Description
800 breast cancer patients who fulfill the eligibiltiy criteria will be selected from the NUH breast cancer registry (400 for training, 400 for validation). Eligible patients should have at least 5 ye...
Eligibility Criteria
Inclusion
- \- Eligible patients should have at least 5 years' follow-up at NUH and have an available archival paraffin-embedded tumor block stored at the Department of Pathology, NUH
Exclusion
- Non breast cancer patients
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
End Date :
December 1 2014
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01247480
Start Date
September 1 2010
End Date
December 1 2014
Last Update
January 22 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National University Hospital
Singapore, Singapore, Singapore